Skip to main content

Table 2 Clinicopathological characteristics of 51 PTC patients

From: BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features

Characteristics Patients (n) Percent (%)
Sex   
 Female 37 72.5
 Male 14 27.5
Age (years) 41.7 ± 11.6  
 ≤ 45 32 62.7
 > 45 19 37.3
Tumor location   
 Unilateral 20 39.2
 Bilateral 31 60.8
Tumor size (cm/mean) 1.7 ± 0.8  
Multifocality   
 Single 15 29.4
 Multiple (≥ 2) 36 70.6
Extracapsular invasion   
 No 24 47.1
 Yes 27 52.9
Extrathyroid extension   
 No 43 84.3
 Yes 8 15.7
Hashimoto’s disease   
 No 45 88.2
 Yes 6 11.8
Central LNM   
 No 19 37.3
 Yes 32 62.7
Lateral LNM   
 No 34 66.7
 Yes 17 33.3
TNM stage   
 T1 26 51.0
 T2 17 33.3
 T3 8 15.7
  1. LNM lymph node metastasis; TNM tumor-node-metastasis